miércoles, 8 de enero de 2020

Pear Therapeutics licenses voice biomarkers for dementia - STAT

Pear Therapeutics licenses voice biomarkers for dementia - STAT

Daily Recap

STAT Plus: Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders

By CASEY ROSS


ADOBE
Pear Therapeutics is licensing voice biomarkers to improve treatment for illnesses ranging from Alzheimer’s to insomnia and substance use disorder.

No hay comentarios: